Profile data is unavailable for this security.
About the company
Sedana Medical AB (publ) is a Sweden-based medical technology company. It develops, markets and sales medical devices and conducts drug development for future projects around AnaConDa technology. The AnaConDa technology delivery enables of volatile anaesthetics to invasively ventilated patients. The products portfolio comprises disposable medical devices AnaConDa for administration of volatile anaesthetics, AnaConDa syringes, FlurAbsorb charcoal filters for removing halogenated hydrocarbon anaesthetic gases, different lines and connectors which can be used to connect the FlurAbsorb filter, adaptors, among others. The Company’s main shareholders are board members, Linc AB and Magiola Consulting AB.
- Revenue in SEK (TTM)164.91m
- Net income in SEK-22.83m
- Incorporated2004
- Employees83.00
- LocationSedana Medical AB (publ)Vendevagen 89DANDERYD 182 32SwedenSWE
- Phone+46 812405200
- Fax+46 812405296
- Websitehttps://sedanamedical.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| C Rad AB | 424.62m | 35.43m | 1.31bn | 87.00 | 37.95 | 4.96 | 29.41 | 3.09 | 1.05 | 1.05 | 12.57 | 8.03 | 1.14 | 4.42 | 3.82 | 4,880,632.00 | 9.60 | 5.09 | 13.75 | 7.02 | 45.83 | 43.12 | 8.41 | 4.86 | 2.27 | 139.13 | 0.0064 | 0.00 | 40.92 | 17.44 | 375.05 | 10.89 | 33.69 | -- |
| ADDvise Group AB (publ) | 1.48bn | 110.80m | 1.51bn | 620.00 | 24.90 | 3.48 | 6.72 | 1.02 | 0.5864 | 0.5864 | 7.84 | 4.20 | 0.5506 | 6.73 | 5.52 | 2,365,224.00 | 4.14 | 3.72 | 5.17 | 4.77 | 47.63 | 48.95 | 7.51 | 5.89 | 1.09 | 2.99 | 0.6608 | 0.9405 | 44.30 | 38.62 | 27.62 | -- | 30.35 | -- |
| Stille AB | 362.16m | 35.58m | 1.77bn | 142.00 | 32.74 | 2.74 | 33.10 | 4.88 | 6.00 | 6.00 | 60.20 | 71.84 | 0.5364 | 1.77 | 7.18 | 3,416,557.00 | 5.27 | 7.03 | 6.35 | 8.19 | 46.76 | 43.93 | 9.82 | 9.85 | 0.9879 | 7.17 | 0.00 | 21.98 | 19.70 | 16.78 | -2.48 | 5.34 | 23.62 | -- |
| Bactiguard Holding AB | 220.81m | -126.19m | 2.20bn | 191.00 | -- | 7.25 | -- | 9.98 | -3.60 | -3.60 | 6.30 | 9.80 | 0.3035 | 4.28 | 6.00 | 1,017,544.00 | -17.35 | -7.56 | -19.82 | -8.81 | 29.87 | 47.91 | -57.15 | -26.28 | 1.64 | -11.90 | 0.4129 | -- | -11.96 | 6.46 | -161.71 | -- | 8.43 | -- |
| Sedana Medical AB (publ) | 164.91m | -22.83m | 2.37bn | 83.00 | -- | 2.40 | 34,914.02 | 14.40 | -0.2299 | -0.2299 | 1.66 | 9.95 | 0.1564 | 1.24 | 8.10 | 2,087,443.00 | -2.17 | -5.77 | -2.28 | -6.08 | 70.50 | 64.06 | -13.85 | -36.13 | 7.38 | -- | 0.0043 | -- | 25.23 | 21.59 | 18.90 | -- | 42.12 | -- |
| Detection Technology Oyj | -1.16tn | -1.16tn | 2.89bn | 478.00 | -- | 3.40 | -- | -- | -- | -- | -- | 4.97 | -- | -- | -- | -- | -- | 9.34 | -- | 11.96 | -- | 47.44 | -- | 8.22 | 3.13 | -- | 0.081 | 53.45 | 5.29 | 2.02 | 7.55 | -18.03 | -14.88 | -9.55 |
| BICO Group AB | 2.26bn | -1.61bn | 3.03bn | 837.00 | -- | 1.02 | -- | 1.34 | -22.34 | -26.39 | 31.73 | 42.97 | 0.3398 | 2.33 | 4.14 | 2,555,996.00 | -24.19 | -- | -27.59 | -- | 50.48 | -- | -71.20 | -- | 1.95 | -13.81 | 0.3933 | -- | 6.09 | -- | -1,889.33 | -- | -- | -- |
| Medistim ASA | 532.56m | 102.86m | 3.29bn | 152.00 | 31.95 | 7.63 | 25.90 | 6.18 | 5.60 | 5.60 | 29.01 | 23.48 | 1.03 | 0.7765 | 6.15 | 3,492,704.00 | 19.95 | 22.93 | 24.07 | 28.52 | 79.02 | 78.25 | 19.31 | 20.64 | 2.99 | -- | 0.0206 | 75.25 | 7.00 | 10.06 | -8.91 | 12.72 | 0.033 | 14.87 |
Data as of May 17 2024. Currency figures normalised to Sedana Medical AB (publ)'s reporting currency: Swedish Krona SEK
36.49%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Swedbank Robur Fonder ABas of 29 Feb 2024 | 9.12m | 9.18% |
| E. �hman J :or Fonder ABas of 03 Apr 2024 | 6.79m | 6.83% |
| Handelsbanken Fonder ABas of 30 Apr 2024 | 5.23m | 5.27% |
| Highclere International Investors LLPas of 31 Dec 2023 | 3.31m | 3.33% |
| Premier Fund Managers Ltd.as of 30 Nov 2023 | 2.74m | 2.76% |
| AMF Fonder ABas of 29 Feb 2024 | 2.49m | 2.51% |
| Joh. Berenberg, Gossler & Co. KG (Investment Management)as of 30 Dec 2022 | 2.00m | 2.01% |
| Tredje AP-fondenas of 31 Dec 2023 | 1.74m | 1.75% |
| Amundi Asset Management SA (Investment Management)as of 28 Mar 2024 | 1.45m | 1.46% |
| AXA Investment Managers (Paris) SAas of 31 Jan 2024 | 1.38m | 1.39% |
More ▼
Data from 31 Dec 2023 - 08 May 2024Source: FactSet Research Systems Inc.
